Ellagic Acid Inhibits the Proliferation of Human Pancreatic Carcinoma PANC-1 Cells in Vitro and in Vivo

Overview

Journal Oncotarget

Specialty Oncology

Date 2017 Jan 31

PMID 28135203

Citations 22

Authors

Hao Cheng

Chenglin Lu

Ribo Tang

Yiming Pan

Shanhua Bao

Yudong Qiu

Min Xie

Affiliations

Soon will be listed here.

Abstract

Ellagic aicd (EA), a dietary polyphenolic compound found in plants and fruits, possesses various pharmacological activities. This study investigated the effect of EA on human pancreatic carcinoma PANC-1 cells both in vitro and in vivo; and defined the associated molecular mechanisms. In vitro, the cell growth and repairing ability were assessed by CCK-8 assay and wound healing assay. The cell migration and invasion activity was evaluated by Tanswell assay. In vivo, PANC-1 cell tumor-bearing mice were treated with different concentrations of EA. We found that EA significantly inhibited cell growth, cell repairing activity, and cell migration and invasion in a dose-dependent manner. Treatment of PANC-1 xenografted mice with EA resulted in significant inhibition in tumor growth and prolong mice survival rate. Furthermore, flow cytometric analysis showed that EA increased the percentage of cells in the G1 phase of cell cycle. Western blot analysis revealed that EA inhibited the expression of COX-2 and NF-κB. In addition, EA reversed epithelial to mesenchymal transition by up-regulating E-cadherin and down-regulating Vimentin. In summary, the present study demonstrated that EA inhibited cell growth, cell repairing activity, cell migration and invasion in a dose-dependent manner. EA also effectively inhibit human pancreatic cancer growth in mice. The anti-tumor effect of EA might be related to cell cycle arrest, down-regulating the expression of COX-2 and NF-κB, reversing epithelial to mesenchymal transition by up-regulating E-cadherin and down-regulating Vimentin. Our findings suggest that the use of EA would be beneficial for the management of pancreatic cancer.

Citing Articles

Berries vs. Disease: Revenge of the Phytochemicals.

Lamenza F, Upadhaya P, Roth P, Shrestha S, Jagadeesha S, Horn N Pharmaceuticals (Basel). 2024; 17(1).

PMID: 38256917 PMC: 10818490. DOI: 10.3390/ph17010084.

A comprehensive review on Ellagic acid in breast cancer treatment: From cellular effects to molecular mechanisms of action.

Golmohammadi M, Zamanian M, Jalal S, Noraldeen S, Ramirez-Coronel A, Oudaha K Food Sci Nutr. 2023; 11(12):7458-7468.

PMID: 38107139 PMC: 10724635. DOI: 10.1002/fsn3.3699.

Ellagic Acid and Cancer Hallmarks: Insights from Experimental Evidence.

cizmarikova M, Michalkova R, Mirossay L, Mojzisova G, Zigova M, Bardelcikova A Biomolecules. 2023; 13(11).

PMID: 38002335 PMC: 10669545. DOI: 10.3390/biom13111653.

Modulation of hypoxia-inducible factor-1 signaling pathways in cancer angiogenesis, invasion, and metastasis by natural compounds: a comprehensive and critical review.

Fakhri S, Moradi S, Faraji F, Kooshki L, Webber K, Bishayee A Cancer Metastasis Rev. 2023; 43(1):501-574.

PMID: 37792223 DOI: 10.1007/s10555-023-10136-9.

The potential role of plant secondary metabolites on antifungal and immunomodulatory effect.

Zhou X, Zeng M, Huang F, Qin G, Song Z, Liu F Appl Microbiol Biotechnol. 2023; 107(14):4471-4492.

PMID: 37272939 PMC: 10240486. DOI: 10.1007/s00253-023-12601-5.

References

De Craene B, Berx G . Regulatory networks defining EMT during cancer initiation and progression. Nat Rev Cancer. 2013; 13(2):97-110. DOI: 10.1038/nrc3447. View

Pilarsky C, Ammerpohl O, Sipos B, Dahl E, Hartmann A, Wellmann A . Activation of Wnt signalling in stroma from pancreatic cancer identified by gene expression profiling. J Cell Mol Med. 2008; 12(6B):2823-35. PMC: 3828895. DOI: 10.1111/j.1582-4934.2008.00289.x. View

Hamacher R, Diersch S, Scheibel M, Eckel F, Mayr M, Rad R . Interleukin 1 beta gene promoter SNPs are associated with risk of pancreatic cancer. Cytokine. 2009; 46(2):182-6. DOI: 10.1016/j.cyto.2009.01.005. View

Mahadevan D, Von Hoff D . Tumor-stroma interactions in pancreatic ductal adenocarcinoma. Mol Cancer Ther. 2007; 6(4):1186-97. DOI: 10.1158/1535-7163.MCT-06-0686. View

Banerjee S, Zhang Y, Ali S, Bhuiyan M, Wang Z, Chiao P . Molecular evidence for increased antitumor activity of gemcitabine by genistein in vitro and in vivo using an orthotopic model of pancreatic cancer. Cancer Res. 2005; 65(19):9064-72. DOI: 10.1158/0008-5472.CAN-05-1330. View

Lee S, Kwak C, Lee S, Ha S, Park J, Chung T . Anti-Inflammatory Effect of Ascochlorin in LPS-Stimulated RAW 264.7 Macrophage Cells Is Accompanied With the Down-Regulation of iNOS, COX-2 and Proinflammatory Cytokines Through NF-κB, ERK1/2, and p38 Signaling Pathway. J Cell Biochem. 2015; 117(4):978-87. DOI: 10.1002/jcb.25383. View

Akhtar K, Ara A, Siddiqui S, Sherwani R . Transition of Immunohistochemical Expression of E-Cadherin and Vimentin from Premalignant to Malignant Lesions of Oral Cavity and Oropharynx. Oman Med J. 2016; 31(3):165-9. PMC: 4852082. DOI: 10.5001/omj.2016.33. View

Krausch M, Kroepil F, Lehwald N, Lachenmayer A, Schott M, Anlauf M . Notch 1 tumor expression is lacking in highly proliferative pancreatic neuroendocrine tumors. Endocrine. 2012; 44(1):182-6. DOI: 10.1007/s12020-012-9850-5. View

Long J, Zhang Y, Yu X, Yang J, LeBrun D, Chen C . Overcoming drug resistance in pancreatic cancer. Expert Opin Ther Targets. 2011; 15(7):817-28. PMC: 3111812. DOI: 10.1517/14728222.2011.566216. View

10.

Mann C, Bastianpillai C, Neal C, Masood M, Jones D, Teichert F . Notch3 and HEY-1 as prognostic biomarkers in pancreatic adenocarcinoma. PLoS One. 2012; 7(12):e51119. PMC: 3514220. DOI: 10.1371/journal.pone.0051119. View

11.

Sawai H, Okada Y, Funahashi H, Matsuo Y, Takahashi H, Takeyama H . Interleukin-1alpha enhances the aggressive behavior of pancreatic cancer cells by regulating the alpha6beta1-integrin and urokinase plasminogen activator receptor expression. BMC Cell Biol. 2006; 7:8. PMC: 1388210. DOI: 10.1186/1471-2121-7-8. View

12.

Kunnumakkara A, Guha S, Krishnan S, Diagaradjane P, Gelovani J, Aggarwal B . Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-kappaB-regulated gene products. Cancer Res. 2007; 67(8):3853-61. DOI: 10.1158/0008-5472.CAN-06-4257. View

13.

Yap A, Crampton M, Hardin J . Making and breaking contacts: the cellular biology of cadherin regulation. Curr Opin Cell Biol. 2007; 19(5):508-14. PMC: 2128038. DOI: 10.1016/j.ceb.2007.09.008. View

14.

Ghoshal S, Trivedi D, Graf G, Loftin C . Cyclooxygenase-2 deficiency attenuates adipose tissue differentiation and inflammation in mice. J Biol Chem. 2010; 286(1):889-98. PMC: 3013048. DOI: 10.1074/jbc.M110.139139. View

15.

Vadhanam M, Ravoori S, Aqil F, Gupta R . Chemoprevention of mammary carcinogenesis by sustained systemic delivery of ellagic acid. Eur J Cancer Prev. 2011; 20(6):484-91. DOI: 10.1097/CEJ.0b013e3283498e00. View

16.

Yamashita T, Nishimura K, Saiki R, Okudaira H, Tome M, Higashi K . Role of polyamines at the G1/S boundary and G2/M phase of the cell cycle. Int J Biochem Cell Biol. 2013; 45(6):1042-50. DOI: 10.1016/j.biocel.2013.02.021. View

17.

Giantonio B, Catalano P, Meropol N, ODwyer P, Mitchell E, Alberts S . Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: results from the Eastern Cooperative Oncology Group Study E3200. J Clin Oncol. 2007; 25(12):1539-44. DOI: 10.1200/JCO.2006.09.6305. View

18.

Buniatian G . Stages of activation of hepatic stellate cells: effects of ellagic acid, an inhibiter of liver fibrosis, on their differentiation in culture. Cell Prolif. 2004; 36(6):307-19. PMC: 6496808. DOI: 10.1046/j.1365-2184.2003.00287.x. View

19.

Jung H, Kim J, Kim W, Oh K, Kim J, Lee H . Intracellular annexin A2 regulates NF-κB signaling by binding to the p50 subunit: implications for gemcitabine resistance in pancreatic cancer. Cell Death Dis. 2015; 6:e1606. PMC: 4669756. DOI: 10.1038/cddis.2014.558. View

20.

Ma Y, Shi C, Zhang Y, Wang L, Liu H, Jia H . The tyrosine kinase c-Src directly mediates growth factor-induced Notch-1 and Furin interaction and Notch-1 activation in pancreatic cancer cells. PLoS One. 2012; 7(3):e33414. PMC: 3316571. DOI: 10.1371/journal.pone.0033414. View